Skip to content
Open access

A Swiss DSG2 Founder Variant Promotes Left Ventricular Thrombus Formation Causing Cardioembolic Stroke in Autosomal Recessive Arrhythmogenic Cardiomyopathy

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

A novel ACM phenotype in patients homozygous for the DSG2 founder variant c.523+2T>C characterized by left ventricular apical fibrosis is identified and highlights a novel pathological feature of ACM and the need for variant and phenotype-specific therapy.

Read PDF

Similar papers

Case report Open access Sep 2026

Phenotypic Transition From Danon Disease to Arrhythmogenic Cardiomyopathy: Multimodality and Histopathologic Evidence.

BACKGROUND Pathogenic variants in lysosome-associated membrane protein 2 (LAMP2) gene cause X-linked Danon disease, associated with hypertrophic cardiomyopathy. Arrhythmogenic cardiomyopathy is characterized by myocardial fibrofatty replacement and ventricular arrhythmias. CASE SUMMARY A 30-year-old woman presented w...

Natália Quintella Sangiorgi Olivetti, Giovana Pereira Belitardo, Felipe Cerqueira Matheus et al. · 0 citations
Case report Open access Aug 2026

Biventricular arrhythmogenic cardiomyopathy due to a PKP2 mutation with severe heart failure and multifocal thromboembolism as the clinically apparent presentation: a case report

Abstract Background Arrhythmogenic cardiomyopathy (ACM) is a genetic myocardial disease classically characterized by ventricular arrhythmias and right ventricular involvement. Biventricular variants involving PKP2 mutations are increasingly recognized but rarely present primarily as severe heart failure and multi-focal...

B. Dao, Thong Minh Chau · 0 citations
Review Aug 2026

Incidence of Atrial and Ventricular Arrhythmias in Patients With Titin Truncating Variants Across the Ventricular Morphofunctional Phenotypic Spectrum.

BACKGROUND Titin truncating variants (TTNtvs), the most common genetic cause of dilated cardiomyopathy (DCM), are over-represented in early-onset atrial fibrillation (AF) and unexplained sudden cardiac arrest/death (SCA/SCD), suggesting they can cause arrhythmias before development of overt ventricular cardiomyopathy....

R. Coderre, William H. Swain, M. Castrichini et al. · 0 citations
Case report Open access Oct 2026

Ventricular Fibrillation in PRKAG2 Cardiomyopathy: A Genetic Arrhythmia Substrate Beyond Wolff-Parkinson-White.

BACKGROUND PRKAG2 syndrome is a rare autosomal dominant glycogen storage cardiomyopathy characterized by left ventricular hypertrophy, ventricular pre-excitation, and progressive conduction system disease. CASE SUMMARY We report the case of a 25-year-old woman with genetically confirmed PRKAG2 syndrome who presented...

Julia Visch, L. Hopman, Danny Holtus et al. · 0 citations
Review Open access Sep 2026

The Multifaceted Role of the FLNC Gene in Hereditary Cardiomyopathies and Prognosis

This narrative review summarizes FLNC molecular biology, genotype-phenotype relationships, imaging features, arrhythmic risk, and implications for clinical management and discusses the limited evidence linking FLNCtv to arrhythmogenic mitral valve prolapse with mitral annular disjunction.

M. d'Apolito, A. Ranaldi, Teresa Gaudiano et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.